Library Subscription: Guest
International Journal of Medicinal Mushrooms

Published 12 issues per year

ISSN Print: 1521-9437

ISSN Online: 1940-4344

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.2 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 1.4 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.3 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00066 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.34 SJR: 0.274 SNIP: 0.41 CiteScore™:: 2.8 H-Index: 37

Indexed in

Gain Access(open in a new tab)
More
Download article Download MARC record(open in a new tab) Get Permissions(open in a new tab)

The Role of Medicinal Mushrooms in Brain Cancer Therapies: Review

Volume 23, Issue 5, 2021, pp. 13-20
DOI: 10.1615/IntJMedMushrooms.2021038277
Get accessDownload
Maria Letizia Gargano
Department of Agricultural and Environmental Sciences, University of Bari "Aldo Moro", Via Amendola, 165/A, I-70126 Bari, Italy; Italian Society of Medicinal Mushrooms, 56125 Pisa, Italy
Giuseppe Venturella
Italian Society of Medicinal Mushrooms, Pisa, Italy; Department of Agricultural, Food and Forest Sciences, University of Palermo, 90128 Palermo, Italy
Filippo Bosco
Italian Society of Medicinal Mushrooms, 56125 Pisa, Italy; Anaesthesia and Intensive Care MiSC AOUP Complementary Medicine Oncology Integrated Breast Unit, University Hospital Trust of Pisa, 56126 Pisa, Italy
Maria Grazia Fabrini
Oncology and Radiotherapy, University Hospital Trust of Pisa, 56126 Pisa, Italy
Wenyuan Gao
School of Pharmaceutical Science and Technology, Tianjin University, Nankai District, Tianjin 300072, People's Republic of China
Lorenzo Pecoraro
School of Pharmaceutical Science and Technology, Tianjin University, Nankai District, Tianjin 300072, People's Republic of China

ABSTRACT

Medicinal mushrooms are considered an unlimited source of polysaccharides (mainly β-glucans) and polysaccharide-protein complexes and possess various immunological and anticancer properties. In addition, their use in integrative medicine leads to a clear reduction of side effects in patients undergoing chemotherapy or radiotherapy. The literature reports a number of beneficial effects of using mushrooms as health supplements in patients affected by high-grade glioma. The effects of medicinal mushrooms on side effects in patients with brain cancer and a case study report are also described in this review.

KEY WORDS: integrative therapies, brain cancer, glioblastoma, medicinal mushrooms, mycotherapeutic support
REFERENCES

  1. Wrensch M, Minn Y, Chew T, Bondy M, Berger MS. Epidemiology of primary brain cancers: Current concepts and review of the literature. Neuro Oncol. 2002;4:278-99.

  2. Busco S, Buzzoni C, Mallone S, Trama A, Castaing M, Tognazzo S; AIRTUM Working Group. Italian cancer figures-report 2015: The burden of rare cancers in Italy. Epidemiol Prev. 2006;40:1-120.

  3. Obenauf AC, Massague J. Surviving at a distance: Organ specific metastasis. Trends Cancer. 2015;1(1):76-91.

  4. Stupp R, Wong ET, Kanner AA, Steinberg D, Engelhard H, Heidecke V, Kirson ED, Taillibert S, Liebermann F, Dbaly V, Ram Z, Villano JL, Rainov N, Weinberg U, Schiff D, Kunschner L, Raizer J, Honnorat J, Sloan A, Malkin M, Landolfi JC, Payer F, Mehdorn M, Weil RJ, Pannullo SC, Westphal M, Smrcka M, Chin L, Kostron H, Hofer S, Bruce J, Cosgrove R, Paleologous N, Palti Y, Gutin PH. NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality. Eur J Cancer. 2012;48:2192-202.

  5. Armstrong TS, Gilbert MR. Use of complementary and alternative medical therapy by patients with primary brain tumors. Curr Neurol Neurosci Rep. 2008;8(3):264-8.

  6. Rosenthal DS, Tuner CD, Doherty-Gilman AM, Dean Clower E. Integrative oncology as part of the treatment for brain tumors. Cancer Treat Res. 2009;150:353-62.

  7. Randazzo DM, McSherry F, Herndon JE, Affronti ML, Lipp ES, Flahiff C, Miller E, Woodring S, Boulton S, Desjardins A, Ashley DM, Friedman HS, Peters KB. Complementary and integrative health interventions and their association with health-related quality of life in the primary brain tumor population. Complement Ther Clin Pract. 2019;36:43-8.

  8. Satija A, Bhatnagar S. Complementary therapies for symptom management in cancer patients. Indian J Palliat Car. 2017;23(4):468-79.

  9. Seyfried TN, Kiebish MA, Marsh J, Shelton ML, Huysentruyt C, Mukherjee P. Metabolic management of brain cancer. Bio- chim Biophys Acta. 2011;1807(6):577-94.

  10. Fiorentini G, Sarti D, Milandri C, Dentico P, Mambrini A, Fiorentini C, Mattioli G, Casadei V, Guadagni S. Modulated electrohyperthermia in integrative cancer treatment for relapsed malignant glioblastoma and astrocytoma: Retrospective multi-center controlled study. Integr Cancer Ther. 2018;18:1-11.

  11. Kofron CP, Chapman A. Breast cancer with brain metastases: Perspective from a long-term survivor integrative cancer therapies. Integr Cancer Ther. 2020;19:1534735419890017.

  12. Gargano ML, van Griensven LJLD, Isikhuemhen OS, Lindequist, U, Venturella G, Wasser SP, Zervakis GI. Medicinal mushrooms: Valuable biological resources of high exploitation potential. Plant Biosyst. 2017;151(3):548-65.

  13. Ito T, Urushima H, Sakaue M, Yukawa S, Honda H, Hirai K, Igura T, Hayashi N, Maeda K, Kitagawa T, Kondo K. Reduction of adverse effects by a mushroom product, active hexose correlated compound (AHCC) in patients with advanced cancer during chemotherapy-the significance of the levels of HHV-6 DNA in saliva as a surrogate biomarker during chemotherapy. Nutr Cancer. 2014;66(3):377-82.

  14. Konno S. Synergistic potentiation of D-fraction with vitamin C as possible alternative approach for cancer therapy. Int J Gen Med. 2009;2:91-108.

  15. Kodama N, Komuta K, Nanba H. Can maitake MD-fraction aid cancer patients? Altern Med Rev. 2002;7(3):236-9.

  16. Wang C, Shi S, Chen Q, Lin S, Wang R, Wang S, Chen C. Antitumor and immunomodulatory activities of Ganoderma lucidum polysaccharides in glioma-bearing rats. Integr Cancer Ther. 2018;17(3):674-83.

  17. Soderberg-Naucler C, Johnsen JI. Cytomegalovirus infection in brain tumors. A potential new target for therapy? Oncoimmunology. 2012;1(5):739-40.

  18. Tochikura TS, Nakashima H, Hirose K, Yamamoto N. A biological response modifier, PSK, inhibits human immunodeficiency virus infection in vitro. Biochem Biophys Res Commun. 1987;148:726-33.

  19. Szallasi A, Biro T, Szabo T, Modarres S, Petersen M, Klusch A, Blumberg PM, Krause JE, Sterner O. A non-pungent triprenyl phenol of fungal origin, scutigeral, stimulates rat dorsal root ganglion neurons via interaction at vanilloid receptors. Br J Pharmacol. 1999;126:1351-8.

  20. Liu J. Biologically active substances from mushrooms in Yunnan, China. Heterocycles. 2002;57(1):157-67.

  21. Lindequist U, Niedermeyer THJ, Julich WD. The pharmacological potential of mushrooms. Evid Based Complement Alternat Med. 2005;2(3):285-99.

  22. Jin Y, Meng X, Qiu Z, Su Y, Yu P, Qu P. Anti-tumor and anti-metastatic roles of cordycepin, one bioactive compound of Cordyceps militaris. Saudi J Biol Sci. 2018;25(5):991-5.

  23. Zhao M, Chen L, Chen W, Meng Z, Hu K, Du S, Zhang L, Yin L, Wu B, Guan Y-Q. Packaging cordycepin phycocyanin micelles for the inhibition of brain cancer. J Mater Chem B. 2017;30(5):6016-26.

  24. Hueng DY, Hsieh CH, Cheng YC, Tsai WC, Chen Y. Cordycepin inhibits migration of human glioblastoma cells by affecting lysosomal degradation and protein phosphatase activation. J Nutr Biochem. 2017;41:109-16.

  25. Chaicharoenaudomrung N, Jaroonwitchawan T, Noisa P. Cordycepin induces apoptotic cell death of human brain cancer through the modulation of autophagy. Toxicol In Vitro. 2018;46:113-21.

  26. Kim CS, Lee S-Y, Cho S-H, Ko Y-M, Kim B-H, Kim H-J, Park J-C, Kim D-K, Ahn H, Kim B-O, Lim S-H, Chun HS, Kim DK. Cordyceps militaris induces the IL-18 expression via its promoter activation for IFN-y production. J Ethnopharmacol. 2008;120:366-71.

  27. Schmidt ML, Kuzmanoff KL, Ling-Indeck L, Pezzuto JM. Betulinic acid induces apoptosis in human neuroblastoma cell lines. Eur J Cancer. 2997;33(12):2007-10.

  28. Mullauer FB, Kessler JH, Medema JP. Betulinic acid, a natural compound with potent anticancer effects. Anticancer Drugs. 2010;1(3):215-27.

  29. Fulda S, Jeremias I, Steiner HH, Pietsch T, Debatin KM. Betulinic acid: A new cytotoxic agent against malignant brain tumour cells. Int J Cancer. 1999;82(3):435-41.

  30. Ning XB, Luo Q, Li C, Ding ZY, Pang J, Zhao C. Inhibitory effects of a polysaccharide extract from the Chaga medicinal mushroom, Inonotus obliquus (higher Basidiomycetes), on the proliferation of human neurogliocytoma cells. Int J Med Mushrooms. 2014;16(1):29-36.

  31. Konno S, Chu K, Feuer N, Phillips J, Choudhury M. Potent anticancer effects of bioactive mushroom extracts (Phellinus linteus) on a variety of human cancer cells. J Clin Med Res. 2015;7(2):76-82.

  32. Zhou B, Fu Q, Song S-S, Zheng H-L, Wei Y-Z. Inhibitory effect of schizophyllan on rat glioma cells. Bangladesh J Pharmacol. 2015;10:759-64.

  33. Tiwari RK, Singh S, Gupta CL, Pandey P, Singh VK, Sayyed U, Shekh R, Bajpai P. Repolarization of glioblastoma macrophage cells using non-agonistic dectin-1 ligand encapsulating TLR-9 agonist: Plausible role in regenerative medicine against brain tumor. Int J Neurosci. 2020;19:1-8.

  34. Altieri R, Fontanella M, Agnoletti A, Panciani PP, Spena G, Crobeddu E, Pilloni G, Tardivo V, Lanotte M, Zenga F, Ducati A, Garbossa D. Role of nitric oxide in glioblastoma therapy: Another step to resolve the terrible puzzle? Transl Med UniSa. 2015;12:54-9.

  35. Ruimi N, Petrova RD, Agbaria R, Sussan S, Wasser SP, Reznick AZ, Mahajna J. Inhibition of TNFa-induced iNOS expression in HSV-tk transduced 9L glioblastoma cell lines by Marasmius oreades substances through NF-KB- and MAPK-dependent mechanisms. Mol Biol Rep. 2010;37(8):3801-12.

  36. Mulpur BH, Burt Nabors L, Thompson RC, Olson JJ, La Rocca RV, Thompson Z, Egan KM. Complementary therapy and survival in glioblastoma. Neuro-Oncol Practice. 2015;2(3):122-6.

  37. Wong KH, Sabaratnam V, Abdullah N, Naidu M, Keynes R. Activity of aqueous extracts of lion's mane mushroom Hericium erinaceus (Bull.: Fr.) Pers. (Aphyllophoromycetidae) on the neural cell line NG108-15. Int J Med Mushrooms. 2007;9:57-65.

  38. Durgo K, Koncar M, Komes D, Belscak-Cvitanovic A, Franekic J, Jakopovich I, Jakopovich N, Jakopovich B. Cytotoxicity of blended versus single medicinal mushroom extracts on human cancer cell lines: Contribution of polyphenol and polysaccharide content. Int J Med Mushrooms. 2013;15(5):435-48.

  39. Schmiegelow M, Feldt-Rasmussen U, Rasmussen AK, Lange M, Poulsen HS, Muller J. Assessment of the hypothalamo-pituitary-adrenal axis in patients treated with radiotherapy and chemotherapy for childhood brain tumor. J Clin Endocrinol Metab. 2003;88(7):3149-54.

  40. Ryan JL, Carroll JK, Ryan EP, Mustian KM, Fiscella K, Morrow GR. Mechanisms of cancer-related fatigue. Oncologist. 2007;12(1):22-34.

  41. Alschuler L, Gazella KA. Natural interventions for post-treatment cancer-related fatigue spotlight on ginseng, Rhodiola, and medicinal mushrooms. Nat Med J. 2014;6(11).

  42. Geng P, Siu K-C, Wang Z, Wu J-Y. Antifatigue functions and mechanisms of edible and medicinal mushrooms. Biomed Res Int. 2017;2017:9648496.

  43. Leser M, Ledesma N, Bergerson S, Trujillo E, eds. Oncology nutrition for clinical practice. Cleveland, OH: Academy of Nutrition and Dietetics; 2013.

  44. Ahmed H, Aslam M. Effect of Ganoderma lucidum (reishi) on hematological parameters in Wistar rats. Int J Med Res Health Sci. 2018;7(3):151-7.

  45. Lee K-H, Morris-Natschke SL, Yang X, Huang R, Zhou T, Wu SF, Shi Q, Itokawa H. Recent progress of research on medicinal mushrooms, foods, and other herbal products used in traditional Chinese medicine. J Trad Complement Med. 2012;2(2):1-12.

  46. Wang C-Z, Basila D, Aung HH, Mehendale SR, Chang W-T, McEntee E, Guan X, Yuan C-S. Effects of Ganoderma lucidum extract on chemotherapy-induced nausea and vomiting in a rat model. Am J Chin Med. 2005;33(5):807-15.

  47. Kim TI, Park SJ, Choi CH, Lee SK, Kim WH. Effect of ear mushroom (Auricularia) on functional constipation. Korean J Gastroenterol. 2004;44(1):34-41.

  48. Namba H. Maitake D-fraction: Healing and preventive potential for cancer. J Orthmol Med. 1997;12:43-9.

  49. Zhou S, Gao Y, Chan E. Clinical trials for medicinal mushrooms: Experience with Ganoderma lucidum (W.Curt.: Fr.) Lloyd (lingzhi mushroom). Int J Med Mushrooms. 2015;7(1-2):111-8.

  50. Wasser SP. Medicinal mushroom science: Current perspectives, advances, evidences, and challenges. Biomed J. 2014;37(6):345-68.

CITED BY

  1. Yuan Bao-Zhong, Sun Jie , Visualization Analysis of Medicinal Mushrooms Research Topic Based on Web of Science , International Journal of Medicinal Mushrooms, 25, 1, 2023. Crossref

10735 Article views 4562 Article downloads Metrics
10735 VIEWS 4562 DOWNLOADS 1 Crossref CITATIONS Google
Scholar CITATIONS

Articles with similar content:

Therapeutic Effects of Substances Occurring in Higher Basidiomycetes Mushrooms: A Modern Perspective Critical Reviews™ in Immunology, Vol.19, 1999, issue 1
Solomon P. Wasser, Alexander L. Weis
Antibacterial and Antiviral Value of the Genus Ganoderma P. Karst. Species (Aphyllophoromycetideae): A Review International Journal of Medicinal Mushrooms, Vol.5, 2003, issue 3
Yihuai Gao, Min Huang, Anlong Xu, Shufeng Zhou
Medicinal Properties of Substances Occurring in Higher Basidiomycetes Mushrooms: Current Perspectives (Review) International Journal of Medicinal Mushrooms, Vol.1, 1999, issue 1
Solomon P. Wasser, Alexander L. Weis
Medicinal Mushrooms in Human Clinical Studies. Part I. Anticancer, Oncoimmunological, and Immunomodulatory Activities: A Review International Journal of Medicinal Mushrooms, Vol.19, 2017, issue 4
Solomon P. Wasser
Beneficial Effects of Edible and Medicinal Mushrooms on Health Care International Journal of Medicinal Mushrooms, Vol.3, 2001, issue 4
Tetsuro Ikekawa

Latest Issue

Anti-Hyperglycemic Effect of the Brown Slime Cap Mushroom Chroogomphus rutilus (Agaricomycetes) Crude Polysaccharide In Vitro and In Vivo Lichao Guo, Qingguo Yao, Jianhua Lv, Zhuang Li, Li-An Wang, Jinxiu Zhang Effects of Outdoor-Grown Royal Sun Medicinal Mushroom Agaricus brasiliensis KA21 (Agaricomycetes) Fruiting Body on Canine Malassezia Dermatitis Akitomo Motoi, Katsuya Tajima, Masuro Motoi, Katsuaki Nishihara, Daisuke Yamanaka, Ken-ichi Ishibashi, Naohito Ohno, Yoshiyuki Adachi

Forthcoming Articles

Biochemical properties and antithrombotic effect of a serine protease isolated from medicinal mushroom Pycnoporus coccineus (Polyporaceae) Jun-Hui Choi, Seung Kim Exploring the Functional Properties and Nutritional Values of Coloured Oyster Mushrooms Species of Genus Pleurotus (Agaricomycetes): A Review Nurul Izzati Medihi, Zaibunnisa Abdul Haiyee, Patmawati Patmawati, Sukor Rashidah, Raseetha Siva Influence of Drying Temperatures on Colour Variation, Phenolic Compounds and Multi-Elemental Composition of Some Culinary- Medicinal Mushrooms Nur-Amirah Izzah Nasarudin, Azilah Abdul-Malek , Nurulain Syuhada Mohamad Yazid, Sukor Rashidah, Jegadeesh Raman, Raseetha Siva Anti-hyperuricaemic Activity and Potential Mechanisms of Mushrooms: A Review of Preclinical Studies Chun-Hong Lai, Hui-Chen Lo Taxonomic Identification and Nutritional Profiling of Wild Isolates of the Pink Oyster Mushroom Pleurotus djamor (Agaricomycetes) from Northwestern Himalayas (India) Shikha Guleria, Savita Jandaik, Preeti Thakur Chemical composition and antimicrobial properties of Morchella crassipes from Kashmir Valley, India MEHRAJUDDIN TALIE, John Mohd War, Anees Un Nisa, Asif Hamid Dar, Abdul Hamid Wani, Mohd Yaqub Bhat
Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections Prices and Subscription Policies Begell House Contact Us Language English 中文 Русский Português German French Spain